Svetomir Nenad Markovic, MD, PhD

  • 8090 Citations
  • 51 Scopus h-Index
1976 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1989 2020

2020

Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients

Manohar, S., Thongprayoon, C., Cheungpasitporn, W., Markovic, S. N. & Herrmann, S. M., Feb 2020, In : Kidney International Reports. 5, 2, p. 149-158 10 p.

Research output: Contribution to journalArticle

Open Access
Transplants
Kidney
Safety
Allografts
Transplantation Tolerance
2019

A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1

Block, M. S., Nevala, W. K., Pang, Y. P., Allred, J. B., Strand, C. & Markovic, S. N., Aug 1 2019, In : Melanoma research. 29, 4, p. 420-427 8 p.

Research output: Contribution to journalArticle

resiquimod
Melanoma
Vaccines
Clinical Trials
Appointments and Schedules

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
1 Citation (Scopus)

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy

Failing, J. J., Dudek, O. A., Marin Acevedo, J. A., Chirila, R. M., Dong, H. M., Markovic, S. N. & Dronca, R. S., Aug 1 2019, In : Future Oncology. 15, 22, p. 2645-2656 12 p.

Research output: Contribution to journalReview article

Biomarkers
Neoplasms
Sample Size
Immunotherapy
Therapeutics
2 Citations (Scopus)

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics

Correction: Antibody-targeted chemotherapy for the treatment of melanoma (Cancer Research (2016) 76 (3954-3964) DOI: 10.1158/0008-5472.CAN-15-3131)

Nevala, W. K., Buhrow, S. A., Knauer, D. J., Reid, J. M., Atanasova, E. A. & Markovic, S. N., Sep 1 2019, In : Cancer Research. 79, 17, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Melanoma
Emotions
Drug Therapy
Antibodies
Research

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma

Maus, R. L. G., Jakub, J. W., Hieken, T. J., Nevala, W. K., Christensen, T. A., Sutor, S. L., Flotte, T. J. & Markovic, S. N., Dec 2 2019, In : OncoImmunology. 8, 12, e1667742.

Research output: Contribution to journalArticle

Open Access
Melanoma
Skin
Dendritic Cells
Proteomics
Neoplasms
16 Citations (Scopus)

Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma

Mansfield, A., Peikert, T. D., Smadbeck, J., Udell, J. B. M., Garcia-Rivera, E., Elsbernd, L., Erskine, C. L., Van Keulen, V. P., Kosari, F., Murphy, S. J., Ren, H., Serla, V. V., Schaefer Klein, J. L., Karagouga, G., Harris, F. R., Sosa, C., Johnson, S. H., Nevala, W., Markovic, S. N., Bungum, A. O. & 6 others, Edell, E., Dong, H. M., Cheville, J., Aubry, M. C., Jen, J. & Vasmatzis, G., Feb 1 2019, In : Journal of Thoracic Oncology. 14, 2, p. 276-287 12 p.

Research output: Contribution to journalArticle

Mesothelioma
T-Lymphocytes
Carcinogens
Atlases
Asbestos
14 Citations (Scopus)

Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients

Richter, M. D., Crowson, C., Kottschade, L. A., Finnes, H. D., Markovic, S. N. & Thanarajasingam, U., Jan 1 2019, (Accepted/In press) In : Arthritis and Rheumatology.

Research output: Contribution to journalArticle

Muscular Diseases
Therapeutics
Glucocorticoids
Arthritis
Preexisting Condition Coverage

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

Kumar, A. B., Aguilera, J. V., Velazquez, A., Yan, Y., Jakub, J. W., Brewer, J., Hieken, T. J., Block, M. S., Mc Williams, R. R., Otley, C., Markovic, S. N. & Kottschade, L., Jan 1 2019, In : Dermatologic Therapy. e12813.

Research output: Contribution to journalLetter

L-Lactate Dehydrogenase
Melanoma
Serum
39 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
1 Citation (Scopus)

Understanding heterogeneous tumor microenvironment in metastatic melanoma

Yan, Y., Leontovich, A. A., Gerdes, M. J., Desai, K., Dong, J., Sood, A., Santamaria-Pang, A., Mansfield, A., Chadwick, C., Zhang, R., Nevala, W. K., Flotte, T. J., Ginty, F. & Markovic, S. N., Jun 1 2019, In : PloS one. 14, 6, e0216485.

Research output: Contribution to journalArticle

Open Access
Tumor Microenvironment
melanoma
Tumors
Melanoma
neoplasms
2018
18 Citations (Scopus)

Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience

Richter, M. D., Pinkston, O., Kottschade, L. A., Finnes, H. D., Markovic, S. N. & Thanarajasingam, U., Jan 1 2018, (Accepted/In press) In : Arthritis and Rheumatology.

Research output: Contribution to journalArticle

Preexisting Condition Coverage
Rheumatic Diseases
Immunotherapy
Neoplasms
Glucocorticoids
6 Citations (Scopus)

CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment

Enninga, E. A. L., Chatzopoulos, K., Butterfield, J. T., Sutor, S. L., Leontovich, A. A., Nevala, W. K., Flotte, T. J. & Markovic, S. N., Aug 1 2018, In : Journal of Pathology. 245, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

Galectins
Tumor Microenvironment
Myeloid Cells
Macrophages
Neoplasms
6 Citations (Scopus)

Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials

Jeter, J. M., Bowles, T. L., Curiel-Lewandrowski, C., Swetter, S. M., Filipp, F. V., Abdel-Malek, Z. A., Geskin, L. J., Brewer, J. D., Arbiser, J. L., Gershenwald, J. E., Chu, E. Y., Kirkwood, J. M., Box, N. F., Funchain, P., Fisher, D. E., Kendra, K. L., Marghoob, A. A., Chen, S. C., Ming, M. E., Albertini, M. R. & 22 others, Vetto, J. T., Margolin, K. A., Pagoto, S. L., Hay, J. L., Grossman, D., Ellis, D. L., Kashani-Sabet, M., Mangold, A., Markovic, S. N., Nelson, K. C., Powers, J. G., Robinson, J. K., Sahni, D., Sekulic, A. D., Sondak, V. K., Wei, M. L., Zager, J. S., Dellavalle, R. P., Thompson, J. A., Weinstock, M. A., Leachman, S. A. & Cassidy, P. B., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Chemoprevention
Melanoma
Drug Repositioning
Biological Products
31 Citations (Scopus)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Yan, Y., Kumar, A. B., Finnes, H., Markovic, S. N., Park, S. S., Dronca, R. S. & Dong, H. M., Jan 1 2018, In : Frontiers in Immunology. 9, 1 p.

Research output: Contribution to journalReview article

Neoplasms
Radiotherapy
Therapeutics
Drug Therapy
Immunomodulation
19 Citations (Scopus)

Contraction of T cell richness in lung cancer brain metastases

Mansfield, A., Ren, H., Sutor, S., Sarangi, V., Nair, A., Davila, J., Elsbernd, L. R., Udell, J. B., Dronca, R. S., Park, S. S., Markovic, S. N., Sun, Z. D., Halling, K. C., Nevala, W. K., Aubry, M. C., Dong, H. M. & Jen, J., Dec 1 2018, In : Scientific Reports. 8, 1, 2171.

Research output: Contribution to journalArticle

Brain Neoplasms
Lung Neoplasms
Clone Cells
Neoplasm Metastasis
T-Lymphocytes
13 Citations (Scopus)

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., Mansfield, A. S., Park, S. S., Markovic, S. N., Dronca, R. S. & Dong, H., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
T-Lymphocytes
Drug Therapy
Aptitude
Neoplasms
Therapeutics
3 Citations (Scopus)
Autografts
Stem Cell Transplantation
HLA-DR Antigens
Natural Killer Cells
Lymphoma
3 Citations (Scopus)

Integrative genome-wide analysis of long noncoding RNAs in diverse immune cell types of melanoma patients

Wang, L., Felts, S. J., Van Keulen, V. P., Scheid, A. D., Block, M. S., Markovic, S. N., Pease, L. R. & Zhang, Y., Aug 1 2018, In : Cancer Research. 78, 15, p. 4411-4423 13 p.

Research output: Contribution to journalArticle

Long Noncoding RNA
Melanoma
Genome
Blood Cells
Immunotherapy
5 Citations (Scopus)

Neoadjuvant systemic therapy for regionally advanced melanoma

Jakub, J. W., Racz, J. M., Hieken, T. J., Gonzalez, A. B., Kottschade, L. A., Markovic, S. N., Yan, Y. & Block, M. S., May 1 2018, In : Journal of Surgical Oncology. 117, 6, p. 1164-1169 6 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Melanoma
Disease-Free Survival
5 Citations (Scopus)

Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: A pilot study

Markovic, S. N., Galli, F., Suman, V. J., Nevala, W. K., Paulsen, A. M., Hung, J. C., Gansen, D. N., Erickson, L. A., Marchetti, P., Wiseman, G. A. & Signore, A., Jul 1 2018, In : Oncotarget. 9, 54, p. 30268-30278 11 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Melanoma
Interleukin-2
Therapeutics
Safety
2 Citations (Scopus)

Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins

Gonzalez, A. B., Baum, C., Brewer, J. D., Arpey, C. J., Harmsen, W. S., Suman, V. J., Markovic, S. N. & Jakub, J. W., Jan 1 2018, (Accepted/In press) In : Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Melanoma
Incidence
Cicatrix
Recurrence
3 Citations (Scopus)

Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New

Bangalore Kumar, A., Maus, R. & Markovic, S. N., Jul 1 2018, In : Mayo Clinic Proceedings. 93, 7, p. 917-936 20 p.

Research output: Contribution to journalReview article

Immunotherapy
Immunity
Cell- and Tissue-Based Therapy
Immune System Phenomena
Neoplasms
2 Citations (Scopus)

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance)

Vera Aguilera, J., Rao, R. D., Allred, J. B., Suman, V. J., Windschitl, H. E., Kaur, J. S., Maples, W. J., Lowe, V., Creagan, E. T., Erickson, L. A. & Markovic, S. N., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Melanoma
Regulatory T-Lymphocytes
Disease-Free Survival
Medical Futility
Therapeutics
21 Citations (Scopus)

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy

Suciu, S., Eggermont, A. M. M., Lorigan, P., Kirkwood, J. M., Markovic, S. N., Garbe, C., Cameron, D., Kotapati, S., Chen, T. T., Wheatley, K., Ives, N., de Schaetzen, G., Efendi, A. & Buyse, M., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 1

Research output: Contribution to journalArticle

Melanoma
Recurrence
Survival
Interferons
Therapeutics
2 Citations (Scopus)

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAFV600E-mutant melanoma

Harris, A. L., Lee, S. E., Dawson, L. K., Marlow, L. A., Edenfield, B. H., Durham, W. F., Flotte, T. J., Thompson, M., Small, D. L., Synnott, A. J., Markovic, S. N. & Copland, J. A. III., Jan 1 2018, In : Oncotarget. 9, 13, p. 10905-10919 15 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinases
Retinoblastoma
Standard of Care
Melanoma
Heterografts
1 Citation (Scopus)

The basics of cancer immunotherapy

Dong, H. M. & Markovic, S. N., Jan 5 2018, Springer International Publishing. 160 p.

Research output: Book/ReportBook

Immunotherapy
Neoplasms
Physicians
Health Personnel
Immune System
2 Citations (Scopus)

Therapeutic targets of FDA-approved immunotherapies in oncology

Markovic, S. N. & Kumar, A. B., Jan 5 2018, The Basics of Cancer Immunotherapy. Springer International Publishing, p. 21-37 17 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunotherapy
Therapeutics
2017
7 Citations (Scopus)

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

Youland, R. S., Packard, A. T., Blanchard, M. J., Arnett, A. L., Wiseman, G. A., Kottschade, L. A., Dronca, R. S., Markovic, S. N., Olivier, K. R. & Park, S. S., Apr 1 2017, In : Advances in Radiation Oncology. 2, 2, p. 204-210 7 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Positron-Emission Tomography
Melanoma
Radiotherapy
Neoplasm Metastasis
46 Citations (Scopus)

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis

the International Melanoma Meta-Analysis Collaborative Group (IMMCG) & the International Melanoma Meta-Analysis Collaborative Group (IMMCG), Sep 1 2017, In : European Journal of Cancer. 82, p. 171-183 13 p.

Research output: Contribution to journalReview article

Interferons
Meta-Analysis
Melanoma
Disease-Free Survival
Survival
9 Citations (Scopus)

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20 + B-cell lymphoma

Nevala, W. K., Butterfield, J. T., Sutor, S. L., Knauer, D. J. & Markovic, S. N., Apr 5 2017, In : Scientific Reports. 7, 45682.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Paclitaxel
Nanoparticles
Antibodies
Drug Therapy
6 Citations (Scopus)

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, R. A., Kottschade, L. A., Block, M. S., Mc Williams, R. R., Dronca, R. S., Creagan, E. T., Allred, J. B., Lowe, V. & Markovic, S. N., Mar 14 2017, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

Melanoma
Recurrence
Salvage Therapy
Confidence Intervals
Survival
4 Citations (Scopus)
Immunosuppression
Monocytes
Lymphoma
Cytokines
Lymphocytes
46 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
6 Citations (Scopus)

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

Leontovich, A. A., Dronca, R. S., Nevala, W. K., Thompson, M. A., Kottschade, L. A., Ivanov, L. V. & Markovic, S. N., 2017, In : Melanoma Research. 27, 1, p. 32-42 11 p.

Research output: Contribution to journalArticle

Monocytes
Melanoma
Lymphocytes
Drug Therapy
Neoplasms
31 Citations (Scopus)

Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma: Final results from the global, single-arm, phase ii team trial

Guo, J., Carvajal, R. D., Dummer, R., Hauschild, A., Daud, A., Bastian, B. C., Markovic, S. N., Queirolo, P., Arance, A., Berking, C., Camargo, V., Herchenhorn, D., Petrella, T. M., Schadendorf, D., Sharfman, W., Testori, A., Novick, S., Hertle, S., Nourry, C., Chen, Q. & 1 others, Hodi, F. S., Jun 1 2017, In : Annals of Oncology. 28, 6, p. 1380-1387 8 p., mdx079.

Research output: Contribution to journalArticle

Melanoma
Safety
Dacarbazine
Mutation
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
10 Citations (Scopus)

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

Lymphoma
Therapeutics
Safety
Febrile Neutropenia
Everolimus
3 Citations (Scopus)

Endogenous heat-shock protein induction with or without radiofrequency ablation or cryoablation in patients with stage IV melanoma

Domingo-Musibay, E., Heun, J. M., Nevala, W. K., Callstrom, M. R., Atwell, T., Galanis, E., Erickson, L. A. & Markovic, S. N., Sep 1 2017, In : Oncologist. 22, 9

Research output: Contribution to journalArticle

Cryosurgery
Heat-Shock Proteins
Melanoma
Hot Temperature
Cytotoxic T-Lymphocytes
18 Citations (Scopus)

Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management

Huffman, B. M., Kottschade, L. A., Kamath, P. S. & Markovic, S. N., Jul 26 2017, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

Melanoma
Therapeutics
Immunosuppression
Cyclosporine
Adrenal Cortex Hormones
10 Citations (Scopus)

Human melanoma-derived extracellular vesicles regulate dendritic cell maturation

Maus, R. L. G., Jakub, J. W., Nevala, W. K., Christensen, T. A., Noble-Orcutt, K., Sachs, Z., Hieken, T. J. & Markovic, S. N., Mar 29 2017, In : Frontiers in Immunology. 8, MAR, 358.

Research output: Contribution to journalArticle

Dendritic Cells
Melanoma
Chemokines
Neoplasms
Calgranulin B
2 Citations (Scopus)

Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: Bevacizumab, rituximab, and trastuzumab

Butterfield, J. T., Kim, H., Knauer, D. J., Nevala, W. K. & Markovic, S. N., Dec 1 2017, In : Scientific Reports. 7, 1, 14476.

Research output: Contribution to journalArticle

Nanoparticles
Coatings
Peptides
Monoclonal Antibodies
Antibodies
15 Citations (Scopus)

Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

Enninga, E. A. L., Harrington, S. M., Creedon, D. J., Ruano, R., Markovic, S. N., Dong, H. M. & Dronca, R. S., Jan 1 2017, (Accepted/In press) In : American Journal of Reproductive Immunology.

Research output: Contribution to journalArticle

Galectin 1
Galectins
Ligands
Pregnancy
Fetus
43 Citations (Scopus)

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Zimmer, L., Apuri, S., Eroglu, Z., Kottschade, L. A., Forschner, A., Gutzmer, R., Schlaak, M., Heinzerling, L., Krackhardt, A. M., Loquai, C., Markovic, S. N., Joseph, R. W., Markey, K., Utikal, J. S., Weishaupt, C., Goldinger, S. M., Sondak, V. K., Zager, J. S., Schadendorf, D. & Khushalani, N. I., Apr 1 2017, In : European Journal of Cancer. 75, p. 47-55 9 p.

Research output: Contribution to journalArticle

Melanoma
Cell Death
Treatment Failure
Therapeutics
ipilimumab
6 Citations (Scopus)

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

Failing, J. J., Yan, Y., Porrata, L. F. & Markovic, S. N., Jan 1 2017, In : Melanoma Research. 27, 6, p. 596-600 5 p.

Research output: Contribution to journalArticle

Monocytes
Melanoma
Disease-Free Survival
Lymphocytes
Survival
4 Citations (Scopus)

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab±everolimus for metastatic melanoma

Mc Williams, R. R., Allred, J. B., Slostad, J. A., Katipamula, R., Dronca, R. S., Rumilla, K. M., Erickson, L. A., Bryce, A. H., Joseph, R. W., Kottschade, L. A., King, D. M., Leitch, J. M. & Markovic, S. N., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Disease-Free Survival
Therapeutics
82 Citations (Scopus)

Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies

Kao, J. C., Liao, B., Markovic, S. N., Klein, C. J., Naddaf, E., Staff, N. P., Liewluck, T., Hammack, J. E., Sandroni, P., Finnes, H. & Mauermann, M. M., Oct 1 2017, In : JAMA Neurology. 74, 10, p. 1216-1222 7 p.

Research output: Contribution to journalArticle

Antibodies
Therapeutics
Muscular Diseases
Monoclonal Antibodies
Polyradiculoneuropathy
12 Citations (Scopus)

Pembrolizumab induced severe sclerodermoid reaction

Shenoy, N., Esplin, B., Barbosa, N., Wieland, C., Thanarajasingam, U. & Markovic, S. N., 2017, In : Annals of Oncology. 28, 2, p. 432-433 2 p.

Research output: Contribution to journalLetter

pembrolizumab
6 Citations (Scopus)

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma

Epperla, N., Pham, A. Q., Burnette, B. L., Wiseman, G. A., Habermann, T. M., Macon, W. R., Ansell, S. M., Inwards, D. J., Micallef, I., Johnston, P. B., Markovic, S. N., Porrata, L. F., Colgan, J. P., Ristow, K. M., Nowakowski, G. S. & Witzig, T. E., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Therapeutics
1 Citation (Scopus)

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era

Youland, R. S., Blanchard, M. L., Dronca, R. S., Kottschade, L., Markovic, S. N., Olivier, K. R. & Park, S. S., Oct 1 2017, In : Clinical and Translational Radiation Oncology. 6, p. 25-30 6 p.

Research output: Contribution to journalArticle

Open Access
Radiosurgery
Melanoma
Radiotherapy
Neoplasm Metastasis
Survival